Management of Coronary Artery Aneurysms at the Time of Surgical Revascularization

Lawrence E Greiten1, Daniel Laan2, Lyle D Joyce3

  • 1Department of Surgery, University of Arkansas for Medical Sciences, Little Rock, Alaska.

Insights

Management of coronary artery aneurysms (CAAs) during cardiac surgery shows no survival benefit for aneurysm exclusion versus revascularization alone. Current trends favor revascularization, supporting this approach for rare CAA cases.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Vascular Pathology

Background:

  • Coronary artery aneurysms (CAAs) are rare, affecting 1.5%-5% of coronary angiograms.
  • Limited data exist on optimal management strategies for CAAs during cardiac surgery.

Purpose of the Study:

  • To compare the outcomes of CAA exclusion with distal bypass versus revascularization alone in patients undergoing cardiac surgery.
  • To evaluate the impact of different management strategies on mortality, need for interventions, and long-term cardiac function.

Main Methods:

  • Retrospective review of 53 patients with atherosclerotic CAAs undergoing cardiac surgery (1993-2015).
  • Stratification into two groups: exclusion and distal bypass (n=26) versus revascularization alone (n=27).
  • Comparison of 30-day and long-term mortality, subsequent interventions, and cardiac function.

Main Results:

  • No significant difference in 30-day or long-term mortality between exclusion and revascularization alone groups.
  • A shift in practice observed, with exclusion procedures more common earlier and revascularization alone predominating later.
  • Four patients in the revascularization alone group underwent coronary stenting across the aneurysm.

Conclusions:

  • Exclusion of CAAs does not appear to offer a survival advantage over isolated revascularization.
  • Current surgical trends favor revascularization alone for managing CAAs, a practice supported by these findings.
  • Management strategies for CAA are evolving, with a move away from routine exclusion.
Abstract

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
182
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
298
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
173
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
161
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
273
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
184